We first examined the expression of several negative regulators of STAT3 signaling, including suppressor of cytokine signaling (SOCS) members, SOCS2 and SOCS5, and tyrosine phosphatases, PTPN1 and PTPN11, in GCDC-treated HCC cells. This evidence concerns the gene PTPN1 and hepatocellular carcinoma.